ALS TDI

ALS is a progressive disease that damages nerve cells that send signals from the brain to muscles. As communication breaks down, people experience muscle weakness, loss of movement, & paralysis. Our team is working to understand these breakdowns & move research forward faster.

May is ALS Awareness Month, and we’ve got a great lineup of events to support ALS research. Join us and be part of what moves research forward → als.net/als-events/upc…

May is ALS Awareness Month—a time to recognize ALS’s impact and urgency to move research forward. At ALS TDI, we turn promising ideas into potential treatments. Progress depends on participation, partnership, & community. Follow along to learn more → als.net

Our Fight ALS Film Fest returns for year 5—kicking off ALS Awareness Month. 5 powerful films + special guests from each story. Sunny of Sunnystrong and Her ALS Story returns as emcee. Learn more & register: als.net/als-film-fest/

What does ALS TDI’s expansion mean—and why now? Dr. Fernando Vieira shares how growing our team and research capacity will help test more ideas and move potential treatments forward faster. We have the experience, the plan, and we’re ready for what comes next. Stay tuned.

This means more therapies tested, faster progress, and fewer promising ideas left behind. Made possible by Augie's Quest to Cure ALS and supporters like you. Read more: als.net/news/a-turning… (2/2)

ALS research has reached a turning point. More ideas than ever—but too few places can turn them into treatments. To meet this moment, ALS TDI is expanding: doubling our research team and building a new 33,000 sq. ft. lab. (1/2)

ALS research has reached a turning point. On Thursday, ALS TDI CEO and CSO, Fernando Vieira will share how ALS TDI is meeting this moment—and what it means for people living with ALS.

Join us May 15 (3–4 PM ET) for an ALS Town Hall on Champions Insights. Learn how studying higher-risk groups like athletes, veterans, & first responders could help advance ALS research for everyone. Hosted by ALS TDI, @AnswerALS & @augiesquest. Register: als.net/als-town-hall/

Read a letter from Zach Zangl, diagnosed with ALS in 2024 and now on the board of the ALS 100, a golf event raising funds for ALS research at ALS TDI: als.net/news/l-i-v-i-n… Alongside our scientists, team members like Carol are here to help you get involved in the mission.

On 4/20, eight Team ALS TDI runners will take on the world’s most iconic marathon, already raising $160,000+ for ALS research. Thank you to Kerri, Srikanth, Jeff, Elizabeth, Connor, Gavin, Lauren, and Jessica for every mile. Cheer them on or donate: givengain.com/cause/teamalst…

ALS can impact anyone, and no two experiences look the same. Use our #ALSLooksLikeMe generator to complete a short questionnaire and receive a personalized image to share. Help raise awareness ahead of ALS Awareness Month in May: als.net/als-looks-like…

We answer only to the ALS community. That means following the science, being transparent about what we find—and what we don’t—and staying accountable to those who need answers most. Thank you for pushing this work forward.

Meet our Team ALS TDI runners taking on the Schneider Electric Marathon de Paris this Sunday 🇫🇷 Caroline, Jonathan, Holly, and Debbie are heading to the City of Love to turn every mile into momentum toward ending ALS! Help us cheer them on: fundraise.als.net/parisfullmarat…

mRNA therapies could target multiple drivers of ALS—but delivery into the brain remains a major hurdle. ALS TDI is collaborating with Dr. Michael Mitchell (UPenn) to develop lipid nanoparticles (LNPs) to deliver these therapies: als.net/news/mrna-lnp-…

A new month means new ways to show up for the ALS community! Join us this April for events that bring us together and help move ALS research forward. Find more details and upcoming events here: als.net/als-events/upc…

PRISM unites ALS TDI, @lifearc1 & Axol Bioscience to create patient-derived iPSC models reflecting ALS complexity (sporadic + genetic). These models will be widely available to advance target discovery & therapies—powered by ARC participants. Read more: als.net/news/prism-als…

Behind every breakthrough is a community that believes in science. This Science Appreciation Day, we’re celebrating the researchers, participants, and supporters who make progress possible. Because science—powered by people—is how we end ALS.

2/2

Behind every experiment is a decision: Will this bring us closer to a treatment for ALS? At ALS TDI, we use four key questions to guide every project we take on—so we can focus on what matters most: real impact for people living with ALS.